Back to User profile » Dr Fang-Ju Lin
Papers published by Dr Fang-Ju Lin:
Tigecycline-Associated Hypofibrinogenemia and Major Bleeding: Incidence, Predictors, and Clinical Outcomes in a Retrospective Cohort
Huang YT, Yang JS, Huang YM, Tseng YJ, Lin FJ
Infection and Drug Resistance 2026, 19:607775
Published Date: 9 June 2026
Cardiovascular Risks of Aromatase Inhibitors versus Tamoxifen in Postmenopausal Breast Cancer: A Multinational Cohort Study
Hu SC, Gaber CE, Lo C, Su HN, Wang CC, Yeh CF, Hassan L, Pickard AS, Lee TA, Lin FJ
Clinical Epidemiology 2026, 18:547763
Published Date: 13 January 2026
Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies
Lin HY, Hu SC, Pai TY, Lin FJ, Wu CC
Drug Design, Development and Therapy 2025, 19:11941-11949
Published Date: 30 December 2025
Effect of SGLT2 Inhibitors on Diabetes Progression in Statin-Treated Patients: A Population-Based Cohort Study
Cheng JSC, Lin F, Fu CM, Lin S, Wang CY, Huang HY, Wang CC
Clinical Epidemiology 2025, 17:421-433
Published Date: 21 April 2025
Evaluation of the Negative Predictive Value of Methicillin-Resistant Staphylococcus aureus Nasal Swab Screening in the Medical Intensive Care Units and Its Effect on Antibiotic Duration
Tai CH, Liu WL, Pan SC, Ku SC, Lin FJ, Wu CC
Infection and Drug Resistance 2022, 15:1259-1266
Published Date: 24 March 2022